| MNPR Stock | | | USD 19.71 0.71 3.74% |
Monopar Therapeutics semi-deviation technical analysis lookup allows you to check this and other technical indicators for Monopar Therapeutics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
Monopar Therapeutics has current Semi Deviation of 7.94. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.
Semi Deviation | = | SQRT(SV) |
| = | 7.94 | |
Monopar Therapeutics Semi Deviation Peers Comparison
Monopar Semi Deviation Relative To Other Indicators
Monopar Therapeutics is considered to be number one stock in semi deviation category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about
82.27 of Maximum Drawdown per Semi Deviation. The ratio of Maximum Drawdown to Semi Deviation for Monopar Therapeutics is roughly
82.27 Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.